Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population

[1]  D. Zeevi,et al.  Is there a way to reduce the inequity in variant interpretation on the basis of ancestry? , 2022, American journal of human genetics.

[2]  T. de Ravel,et al.  Implementation of fetal clinical exome sequencing: Comparing prospective and retrospective cohorts. , 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

[3]  Xinran Dong,et al.  Use of medical exome sequencing for identification of underlying genetic defects in NICU: Experience in a cohort of 2303 neonates in China , 2021, Clinical genetics.

[4]  G. Rechavi,et al.  A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies , 2021, Scientific Reports.

[5]  Shannon Rego,et al.  Preference for secondary findings in prenatal and pediatric exome sequencing , 2021, Prenatal diagnosis.

[6]  W. Chung,et al.  ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[7]  Pui-Yan Kwok,et al.  Making the case for higher-level classification of results reporting: development and implementation of case-level result categories for genetic testing , 2021 .

[8]  T. Meitinger,et al.  De novo variants in neurodevelopmental disorders—experiences from a tertiary care center , 2021, Clinical genetics.

[9]  Stephan J Sanders,et al.  Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis. , 2020, The New England journal of medicine.

[10]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[11]  N. Leach,et al.  The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG) , 2020, Genetics in Medicine.

[12]  N. Risch,et al.  A novel truncating variant in ring finger protein 113A (RNF113A) confirms the association of this gene with X‐linked trichothiodystrophy , 2019, American journal of medical genetics. Part A.

[13]  M. P. Douglas,et al.  Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS) , 2019, Genetics in Medicine.

[14]  R. Nussbaum,et al.  Response to “The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)” , 2019, Genetics in Medicine.

[15]  S. Scherer,et al.  Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders , 2019, Genetics in Medicine.

[16]  D. Ledbetter,et al.  Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders , 2019, Genetics in Medicine.

[17]  V. Jobanputra,et al.  Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study , 2019, The Lancet.

[18]  L. Hindorff,et al.  Defining and Achieving Health Equity in Genomic Medicine. , 2019, Ethnicity & disease.

[19]  Jay F Rowland,et al.  Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study , 2019, The Lancet.

[20]  N. Risch,et al.  The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. , 2018, American journal of human genetics.

[21]  M. Norton,et al.  What are the goals of prenatal genetic testing? , 2018, Seminars in perinatology.

[22]  David R Williams,et al.  Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice. , 2018, Health affairs.

[23]  L. Lynd,et al.  The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study , 2018, Genetics in Medicine.

[24]  E. Green,et al.  Prioritizing diversity in human genomics research , 2017, Nature Reviews Genetics.

[25]  Dustin Baldridge,et al.  The Exome Clinic and the Role of Medical Genetics Expertise in Interpretation of Exome Sequencing Results , 2017, Genetics in Medicine.

[26]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[27]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[28]  J. Mill,et al.  Advanced paternal age effects in neurodevelopmental disorders—review of potential underlying mechanisms , 2017, Translational Psychiatry.

[29]  S. Fullerton,et al.  Genomics is failing on diversity , 2016, Nature.

[30]  Levi Waldron,et al.  Racial/Ethnic Disparities in Genomic Sequencing. , 2016, JAMA oncology.

[31]  J. Vockley,et al.  New observations on maternal age effect on germline de novo mutations , 2016, Nature Communications.

[32]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[33]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[34]  Yujun Han,et al.  Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios , 2015, Genetics in Medicine.

[35]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[36]  Edouard Henrion,et al.  De Novo Mutations in Moderate or Severe Intellectual Disability , 2014, PLoS genetics.

[37]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[38]  Neil A. Miller,et al.  Next-generation community genetics for low- and middle-income countries , 2012, Genome Medicine.

[39]  Neil A. Miller,et al.  Next-generation community genetics for low- and middle-income countries , 2012, Genome Medicine.

[40]  Francisco M. De La Vega,et al.  Genomics for the world , 2011, Nature.

[41]  L. Hudgins,et al.  Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities , 2010, Genetics in Medicine.

[42]  B. Modell,et al.  Medical genetics in developing countries. , 2004, Annual review of genomics and human genetics.

[43]  M. Kuppermann,et al.  How do women of diverse backgrounds value prenatal testing outcomes? , 2004, Prenatal diagnosis.

[44]  Harleah G. Buck,et al.  A Scoping Review of the Literature , 2021 .

[45]  S. Ferrari,et al.  Author contributions , 2021 .

[46]  E. Prigmore,et al.  Prenatal Assessment of Genomes and Exomes Consortium (2019). Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): A cohort study. Obstetrical and Gynecological Survey , 74 (7), 394-396. , 2019 .

[47]  S. Lalani,et al.  Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature , 2018, Genetics in Medicine.

[48]  M. Loane,et al.  The prevalence of congenital anomalies in Europe. , 2010, Advances in experimental medicine and biology.

[49]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[50]  Bernadette Modell,et al.  Recommendations for introducing genetics services in developing countries , 2003, Nature Reviews Genetics.